Cargando…
Effect of Oral carnosine supplementation on urinary TGF-β in diabetic nephropathy: a randomized controlled trial
BACKGROUND: Activation of the transforming growth factor beta (TGF-β) pathway is a significant contributor to the pathogenesis of diabetic nephropathy. Carnosine is a dipeptide that can inhibit TGF-β synthesis. We tested the hypothesis that carnosine supplement added to standard therapy will result...
Autores principales: | Siriwattanasit, Narongrit, Satirapoj, Bancha, Supasyndh, Ouppatham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235831/ https://www.ncbi.nlm.nih.gov/pubmed/34174842 http://dx.doi.org/10.1186/s12882-021-02434-7 |
Ejemplares similares
-
Urinary angiotensinogen as a potential biomarker of diabetic nephropathy
por: Satirapoj, Bancha, et al.
Publicado: (2014) -
Effect of Sulodexide on Urinary Biomarkers of Kidney Injury in Normoalbuminuric Type 2 Diabetes: A Randomized Controlled Trial
por: Satirapoj, Bancha, et al.
Publicado: (2015) -
Effect of sodium-glucose cotransporter 2 inhibitor on proximal tubular function and injury in patients with type 2 diabetes: a randomized controlled trial
por: Satirapoj, Bancha, et al.
Publicado: (2019) -
Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial
por: Satirapoj, Bancha, et al.
Publicado: (2018) -
Periostin as a Tissue and Urinary Biomarker of Renal Injury in Type 2 Diabetes Mellitus
por: Satirapoj, Bancha, et al.
Publicado: (2015)